No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LBPH240719C30000
- 1.50
- +0.45+42.86%
15min DelayClose Jun 28 15:59 ET
2.50High0.55Low
0.55Open1.05Pre Close107 Volume2 Open Interest30.00Strike Price13.25KTurnover100.54%IV16.54%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type0.3800Delta0.0591Gamma18.02Leverage Ratio-0.0616Theta0.0049Rho6.85Eff Leverage0.0244Vega
Intraday
- 5D
- Daily
News
Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Express News | Longboard Pharmaceuticals Inc : Evercore ISI Raises Target Price to $57 From $44
Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target
Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $60 price target.
Evercore ISI Raises Price Target on Longboard Pharmaceuticals to $57 From $44, Maintains Outperform Rating
Longboard Pharmaceuticals (LBPH) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $32 to $60.
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities